|Fox Chase Cancer Center|
NCCN Member Institution Profile
Learn more about clinical trials at Fox Chase Cancer Center.
Fox Chase Cancer Center was formed in 1974 by the union of American Oncologic Hospital (one of the nation’s first cancer hospitals, established in 1904) and the Institute for Cancer Research. Fox Chase was designated by the National Cancer Institute as one of the nation’s first comprehensive cancer centers that same year. In July 2012, the Center became part of Temple University Health System, marking another major milestone in its history and expanding its ability to provide world-class cancer care.
Fox Chase Cancer Center's 100-bed hospital includes programs on basic, clinical and prevention research; detection and treatment of cancer; and community outreach programs. The Center offers multidisciplinary treatment options to patients with all types of cancers, including rare and difficult-to-manage tumors.
Fox Chase offers a broad range of minimally invasive treatment options for cancer surgery. Surgeons specialize in robotic-assisted surgery for nearly all types of cancer including prostate cancer, kidney cancer, bladder cancer, colon cancer, head and neck cancer, gynecologic cancers, and lung cancer.
Fox Chase scientists and physicians collaborate to conduct clinical research, basic laboratory research and population research. Learn about clinical trials at Fox Chase Cancer Center.